Cannabinoids and glaucoma

I. Tomida, Roger Guy Pertwee, Augusto Azuara-Blanco

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Original languageEnglish
Pages (from-to)708-713
Number of pages5
JournalBritish Journal of Ophthalmology
Volume88
Issue number5
DOIs
Publication statusPublished - May 2004

Keywords

  • INTRAOCULAR-PRESSURE
  • NORMOTENSIVE RABBITS
  • NEUROPROTECTIVE ANTIOXIDANTS
  • TOURETTES-SYNDROME
  • RECEPTOR AGONISTS
  • MARIHUANA SMOKING
  • OCULAR TOXICITY
  • CILIARY BODY
  • HUMAN EYES
  • DELTA-9-TETRAHYDROCANNABINOL

Cite this